Literature DB >> 1976806

Action of FMRFamide on longitudinal muscle of the leech, Hirudo medicinalis.

B J Norris1, R L Calabrese.   

Abstract

1. Nerve terminals associated with longitudinal muscle in the leech show FMRFamide-like immunoreactivity. 2. Structure-activity studies using FMRFamide analogs show that the C-terminal RFamide portion of the molecule is crucial for biological activity on leech longitudinal muscle. 3. The putative protease inhibitor FA (Phe-Ala) increases the peak tension produced by longitudinal muscle in response to superfused FMRFamide and the majority of its analogs, suggesting the presence of peripheral proteases capable of degrading RFamide peptides. 4. FMRFamide decreases the relaxation rate of neurally evoked contractions of longitudinal muscle. FA also decreases the relaxation rate of neurally evoked contractions. 5. Intact and isolated muscle cells respond to superfused FMRFamide with a conductance increase, that leads to depolarization and often with a delayed conductance decrease as the membrane potential is restored to resting levels. 6. The depolarizing response of isolated muscle cells to FMRFamide is dependent on external calcium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976806     DOI: 10.1007/bf00188114

Source DB:  PubMed          Journal:  J Comp Physiol A            Impact factor:   1.836


  41 in total

1.  Purification and characterization of a cardioexcitatory neuropeptide from the central ganglia of a bivalve mollusc.

Authors:  D A Price; M J Greenberg
Journal:  Prep Biochem       Date:  1977

2.  The action of cholinergic antagonists on spontaneous excitatory potentials recorded from the body wall muscles of the leech Hirudo medicinalis.

Authors:  R J Walker; G N Woodruff; G A Kerkut
Journal:  Comp Biochem Physiol       Date:  1970-02-15

3.  A novel active pentapeptide from chicken brain identified by antibodies to FMRFamide.

Authors:  G J Dockray; J R Reeve; J Shively; R J Gayton; C S Barnard
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

4.  Characterization and distribution of FMRFamide immunoreactivity in the rat central nervous system.

Authors:  T L O'Donohue; J F Bishop; B M Chronwall; J Groome; W H Watson
Journal:  Peptides       Date:  1984 May-Jun       Impact factor: 3.750

5.  FMRF-amide-like substances in the leech. II. Bioactivity on the heartbeat system.

Authors:  J R Kuhlman; C Li; R L Calabrese
Journal:  J Neurosci       Date:  1985-09       Impact factor: 6.167

6.  Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine.

Authors:  H Y Yang; W Fratta; E A Majane; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  Small cardioactive peptide-like immunoreactivity and its colocalization with FMRFamide-like immunoreactivity in the central nervous system of the leech Hirudo medicinalis.

Authors:  B D Evans; R L Calabrese
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

8.  AF1, a sequenced bioactive neuropeptide isolated from the nematode Ascaris suum.

Authors:  C Cowden; A O Stretton; R E Davis
Journal:  Neuron       Date:  1989-05       Impact factor: 17.173

9.  FMRFamide inhibition of a molluscan heart is accompanied by increases in cyclic AMP.

Authors:  S D Painter
Journal:  Neuropeptides       Date:  1982-10       Impact factor: 3.286

10.  Pharmacology of FMRFamide in Mytilus catch muscle.

Authors:  Y Muneoka; H Saitoh
Journal:  Comp Biochem Physiol C       Date:  1986
View more
  2 in total

1.  A review of FMRFamide- and RFamide-like peptides in metazoa.

Authors:  Robert J Walker; Sylvana Papaioannou; Lindy Holden-Dye
Journal:  Invert Neurosci       Date:  2010-02-26

2.  Mapping motor neuron activity to overt behavior in the leech. I. Passive biomechanical properties of the body wall.

Authors:  R J Wilson; B A Skierczynski; J K Meyer; R Skalak; W B Kristan
Journal:  J Comp Physiol A       Date:  1996-05       Impact factor: 1.836

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.